Shanghai – September 29, 2026 -- IASO Biotechnology reported a 90% objective response rate and 90% minimal residual disease (MRD) negativity rate for its BCMA-targeted in vivo CAR-T therapy IASO206, generated via a single intravenous infusion without lymphodepleting chemotherapy, in first-in-human Phase 1 data presented as a late-breaking oral session (LBA-11) at the 2026 International Myeloma Society Annual Meeting.
Calgary, AB – September 29, 2026 -- Canadian Pacific Railway Company (CPRC), the wholly owned subsidiary of Canadian Pacific Kansas City Limited (TSX: CP) (NYSE: CP), is issuing C$1.8 billion in notes across four tranches, guaranteed by parent CPKC.
The offering comprises C$500 million of 4.20% Notes due 2030, C$550 million of 4.60% Notes due 2033, C$300 million of 4.90% Notes due 2037 and C$450 million of 5.40% Notes due 2056. The staggered maturity profile spans 4 to 30 years, giving CPKC a blended long-term debt structure.
CPKC stated the funds will be used primarily for refinancing outstanding indebtedness and for general corporate purposes. Until deployed, unused proceeds may be parked in short-term investment-grade securities, money market funds or bank deposits.
Oakland – – September 29, 2026 -- Blue Shield of California has pledged a $300,000 multi-year investment to Alameda County Community Food Bank (ACCFB), marking the first deployment under the nonprofit insurer's new statewide Food as Health initiative.
The funding will expand a program that delivers medically supportive food and nutrition education to eligible Medi-Cal members managing chronic conditions. The investment strengthens infrastructure, data collection, and evaluation systems needed to scale the model beyond its current reach.
Los Angeles and Toronto – September 29, 2026 -- BRC Group Holdings, Inc. (NASDAQ: RILY) has agreed to acquire Sangoma Technologies Corporation (TSX: STC; NASDAQ: SANG) in a deal valuing the communications provider at an enterprise value of approximately $204 million, or C$289 million.
BRC's existing communications businesses and Sangoma generated a combined $441 million in trailing-twelve-month revenue as of June 2026, with $241 million from BRC's units and $200 million from Sangoma. BRC's communications portfolio alone produced approximately $52 million in segment income over the same period.
Wood Dale, Ill. – September 29, 2026 -- AAR CORP. (NYSE: AIR) reported first-quarter fiscal 2027 sales of $918 million, a 24% jump from $739.6 million a year earlier, as the aviation aftermarket supplier simultaneously disclosed a definitive agreement to acquire a 65% controlling interest in MRO Holdings.
The quarter ended September 29, 2026, saw growth across all three core segments. Parts Supply sales rose 31%, driven by 23% organic growth in new parts distribution across commercial and government markets. The Repair, Engineering & Software segment grew 31% on airframe MRO, component MRO, and software activity, while Government Solutions increased 4% on Mobility Systems strength.
Pittsburgh – September 29, 2026 -- Allegheny Health Network (AHN) has secured a $1 million commitment from Greg and Ellen Jordan to fund the Greg and Ellen Jordan Endowed Professorship for Alzheimer's Disease and Related Disorders within its Department of Neurology.
The endowment will fund clinical care, neuroscience research and support programming for patients with Alzheimer's disease, dementia and cognitive impairment. Greg Jordan is chairman of the Board of Directors of Highmark Health since 2025, sits on the board of MSA Safety, and serves as vice chairman of PNC after retiring as PNC's general counsel and chief administrative officer in 2024.
"We have each lost a parent to memory-related diseases, and we know that supporting AHN's research in this field is needed to continue to make progress on finding ways to deal with these challenges," Jordan said.
Pasadena, Calif. – September 29, 2026 -- Alexandria Real Estate Equities, Inc. (NYSE: ARE) has closed an amended $5.0 billion unsecured senior line of credit, pushing the facility's maturity to January 2032 and cutting its borrowing margin by 11 basis points. The amended agreement became effective September 29, 2026.
The amendment moves the facility's maturity date from September 29, 2026 to September 29, 2026, contingent on Alexandria exercising two available six-month extension options, subject to certain conditions. The move preserves the life science REIT's revolving credit capacity and extends its debt maturity ladder.
The applicable borrowing rate falls to SOFR plus 0.725%, down from SOFR plus 0.835%, an 11-basis-point reduction that lowers Alexandria's cost of capital on the facility.
San Diego – September 29, 2026 -- Viking Therapeutics, Inc. (Nasdaq: VKTX) has closed concurrent upsized public offerings totaling approximately $575.0 million in gross proceeds, funding to accelerate its late-stage obesity drug pipeline.
The clinical-stage biopharmaceutical company sold 9,035,714 shares of common stock at $35.00 per share, alongside $258.75 million in aggregate principal amount of 2.00% convertible senior notes due 2032. Both tranches were upsized after underwriters fully exercised their options, adding 1,178,571 shares to the equity offering and $33.75 million to the note offering.
North Canton, Ohio – – September 29, 2026 -- The Timken Company has completed the sale of its belts business assets to Gates Industrial Corporation Ltd. (NYSE: GTES), marking a strategic exit from the belts manufacturing segment. Financial terms of the transaction were not disclosed.
Timken President and CEO Lucian Boldea called the sale "an important milestone in achieving our stated 2028 margin targets," noting the move allows the company to concentrate on its core advanced motion technology capabilities. The divested unit produced a broad line of belts for industrial, commercial and consumer applications.
Dallas – – September 29, 2026 -- ATI Inc. (NYSE: ATI) will hold an Investor Day livestream on Thursday, September 29, 2026, running from 12:30 PM to 3:00 PM ET, during which company leaders will present new financial and strategic targets.
Executives are set to outline the company's transformation to date, its competitive advantages, and profitable growth opportunities across its core end markets. The session will conclude with the unveiling of new corporate targets, giving investors updated benchmarks against which to measure ATI's performance.